{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T14:42:02Z","timestamp":1696344122134},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,7]],"date-time":"2013-11-07T00:00:00Z","timestamp":1383782400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s11239-013-1021-x","type":"journal-article","created":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T14:02:47Z","timestamp":1383746567000},"page":"50-56","source":"Crossref","is-referenced-by-count":3,"title":["Functionally stable plasminogen activator inhibitor-1 in a family with cardiovascular disease and vitiligo"],"prefix":"10.1007","volume":"38","author":[{"given":"Mehmet","family":"Agirbasli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mesut","family":"Eren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songul","family":"Yasar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenan","family":"Delil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Goktay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebru Toksoy","family":"Oner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas E.","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,7]]},"reference":[{"key":"1021_CR1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1346-8138.2010.01139.x","volume":"38","author":"R Yaghoobi","year":"2011","unstructured":"Yaghoobi R, Omidian M, Bagherani N (2011) Vitiligo: a review of the published work. J Dermatol 38:419\u2013431","journal-title":"J Dermatol"},{"issue":"1","key":"1021_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/039463201202500101","volume":"25","author":"A Miniati","year":"2012","unstructured":"Miniati A, Weng Z, Zhang B, Stratigos AJ, Nicolaidou E, Theoharides TC (2012) Neuro-immuno-endocine processes in vitiligo pathogenesis. Int J Immunopathol Pharmacol 25(1):1\u20137","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1021_CR3","first-page":"24","volume":"78","author":"RE Boissy","year":"2012","unstructured":"Boissy RE, Dell\u2019anna ML, Picardo M (2012) On the pathophysiology of vitiligo: possible treatment options. Indian J Dermatol Venereol Leprol 78:24\u201329","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"1021_CR4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","volume":"16","author":"K Ongenae","year":"2003","unstructured":"Ongenae K, Van Geel N, Naeyaert JM (2003) Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 16:90\u2013100","journal-title":"Pigment Cell Res"},{"key":"1021_CR5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1600-0749.2005.00242.x","volume":"18","author":"G Laberge","year":"2005","unstructured":"Laberge G, Mailloux CM, Gowan K, Holland P, Bennett DC, Fain PR et al (2005) Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res 18:300\u2013305","journal-title":"Pigment Cell Res"},{"key":"1021_CR6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1034\/j.1600-0749.2002.1o049.x","volume":"15","author":"S Moretti","year":"2002","unstructured":"Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I, Fabiani M et al (2002) New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 15:87\u201392","journal-title":"Pigment Cell Res"},{"key":"1021_CR7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1529-8019.2011.01416.x","volume":"24","author":"E Wang","year":"2011","unstructured":"Wang E, McElwee KJ (2011) Etiopathogenesis of alopecia areata: why do our patients get it? Dermatol Ther 24:337\u2013347","journal-title":"Dermatol Ther"},{"key":"1021_CR8","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4065\/70.7.628","volume":"70","author":"KH Safavi","year":"1995","unstructured":"Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd (1995) Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 70:628\u2013633","journal-title":"Mayo Clin Proc"},{"key":"1021_CR9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/MOP.0b013e32832db986","volume":"21","author":"L Kos","year":"2009","unstructured":"Kos L, Conlon J (2009) An update on alopecia areata. Curr Opin Pediatr 21:475\u2013480","journal-title":"Curr Opin Pediatr"},{"key":"1021_CR10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1742-1241.2005.00379.x","volume":"59","author":"M Agirbasli","year":"2005","unstructured":"Agirbasli M (2005) Pivotal role of plasminogen-activator inhibitor 1 in vascular disease. Int J Clin Pract 59:102\u2013106","journal-title":"Int J Clin Pract"},{"key":"1021_CR11","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1111\/j.1538-7836.2005.01420.x","volume":"3","author":"DE Vaughan","year":"2005","unstructured":"Vaughan DE (2005) PAI-1 and atherothrombosis. J Thromb Haemost 3:1879\u20131883","journal-title":"J Thromb Haemost"},{"key":"1021_CR12","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1538-7836.2007.02587.x","volume":"5","author":"M Eren","year":"2007","unstructured":"Eren M, Gleaves LA, Atkinson JB, King LE, Declerck PJ, Vaughan DE (2007) Reactive site-dependent phenotypic alterations in plasminogen activator inhibitor-1 transgenic mice. J Thromb Haemost 5:1500\u20131508","journal-title":"J Thromb Haemost"},{"key":"1021_CR13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1160\/TH05-01-0033","volume":"93","author":"C Dellas","year":"2005","unstructured":"Dellas C, Loskutoff DJ (2005) Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease. Thromb Haemost 93:631\u2013640","journal-title":"Thromb Haemost"},{"key":"1021_CR14","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1111\/j.1538-7836.2010.03907.x","volume":"8","author":"N Garg","year":"2010","unstructured":"Garg N, Goyal N, Strawn TL, Wu J, Mann KM, Lawrence DA, Fay WP (2010) Plasminogen activator inhibitor-1 and vitronectin expression level and stoichiometry regulate vascular smooth muscle cell migration through physiological collagen matrices. J Thromb Haemost 8:1847\u20131854","journal-title":"J Thromb Haemost"},{"key":"1021_CR15","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.4049\/jimmunol.171.4.2057","volume":"171","author":"LJ Marshall","year":"2003","unstructured":"Marshall LJ, Ramdin LS, Brooks T, DPhil PC, Shute JK (2003) Plasminogen activator inhibitor-1 supports IL-8-mediated neutrophil transendothelial migration by inhibition of the constitutive shedding of endothelial IL-8\/heparan sulfate\/syndecan-1 complexes. J Immunol 171:2057\u20132065","journal-title":"J Immunol"},{"key":"1021_CR16","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1021\/bi00178a022","volume":"33","author":"DA Lawrence","year":"1994","unstructured":"Lawrence DA, Olson ST, Palaniappan S, Ginsburg D (1994) Engineering plasminogen activator inhibitor 1 mutants with increased functional stability. Biochemistry 33:3643\u20133648","journal-title":"Biochemistry"},{"key":"1021_CR17","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1002\/j.1460-2075.1995.tb07299.x","volume":"14","author":"MB Berkenpas","year":"1995","unstructured":"Berkenpas MB, Lawrence DA, Ginsburg D (1995) Molecular evolution of plasminogen activator inhibitor-1 functional stability. EMBO J 14:2969\u20132977","journal-title":"EMBO J"},{"key":"1021_CR18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00019501-200608000-00003","volume":"17","author":"D Agirbasli","year":"2006","unstructured":"Agirbasli D, Agirbasli M, Williams SM, Phillips JA (2006) Interaction among 5,10 methylenetetrahydrofolate reductase, plasminogen activator inhibitor and endothelial nitric oxide synthase gene polymorphisms predicts the severity of coronary artery disease in Turkish patients. Coron Artery Dis 17:413\u2013417","journal-title":"Coron Artery Dis"},{"key":"1021_CR19","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1398-9995.2005.00948.x","volume":"61","author":"A Pampuch","year":"2006","unstructured":"Pampuch A, Kowal K, Bodzenta-Lukaszyk A, Di Castelnuovo A, Chyczewski L, Donati MB et al (2006) The \u2212675 4G\/5G plasminogen activator inhibitor-1 promoter polymorphism in house dust mite-sensitive allergic asthma patients. Allergy 61:234\u2013238","journal-title":"Allergy"},{"key":"1021_CR20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/01.CIR.0000023186.60090.FB","volume":"106","author":"M Eren","year":"2002","unstructured":"Eren M, Painter CA, Atkinson JB, Declerck PJ, Vaughan DE (2002) Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1. Circulation 106:491\u2013496","journal-title":"Circulation"},{"key":"1021_CR21","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1172\/JCI31942","volume":"117","author":"A Gilhar","year":"2007","unstructured":"Gilhar A, Paus R, Kalish RS (2007) Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Investig 117:2019\u20132027","journal-title":"J Clin Investig"},{"key":"1021_CR22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-4632.2007.03193.x","volume":"46","author":"D Wasserman","year":"2007","unstructured":"Wasserman D, Guzman-Sanchez DA, Scott K, McMichael A (2007) Alopecia areata. Int J Dermatol 46:121\u2013131","journal-title":"Int J Dermatol"},{"issue":"5","key":"1021_CR23","first-page":"367","volume":"17","author":"R Dudda-Subramanya","year":"2007","unstructured":"Dudda-Subramanya R, Alexis AF, Siu K, Sinha AA (2007) Alopecia areata: genetic complexity underlies clinical heterogeneity. Eur J Dermatol 17(5):367\u2013374","journal-title":"Eur J Dermatol"},{"key":"1021_CR24","doi-asserted-by":"crossref","first-page":"10739","DOI":"10.1016\/S0021-9258(18)82047-6","volume":"268","author":"SJ Dawson","year":"1993","unstructured":"Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM (1993) The two allele sequence of a common polymorphism in the promoter of the plasminogen activator inhibitor (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 268:10739\u201310745","journal-title":"J Biol Chem"},{"key":"1021_CR25","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.4049\/jimmunol.175.6.4049","volume":"175","author":"PG Arndt","year":"2005","unstructured":"Arndt PG, Young SK, Worthen GS (2005) Regulation of lipopolysaccharide-induced lung inflammation by plasminogen activator inhibitor-1 through a JNK-mediated pathway. J Immunol 175:4049\u20134059","journal-title":"J Immunol"},{"key":"1021_CR26","doi-asserted-by":"crossref","first-page":"e59782","DOI":"10.1371\/journal.pone.0059782","volume":"8","author":"B Bellei","year":"2013","unstructured":"Bellei B, Pitisci A, Ottoviani M, Ludovici M, Cota C, Luzi F, Dell\u2019Anna ML, Picardo M (2013) Vitiligo: a possible model of degenerative diseases. PLoS ONE 8:e59782","journal-title":"PLoS ONE"},{"key":"1021_CR27","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/sj.ijo.0802778","volume":"28","author":"T Skurk","year":"2004","unstructured":"Skurk T, Hauner H (2004) Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1. Int J Obes Relat Metab Disord 28:1357\u20131364","journal-title":"Int J Obes Relat Metab Disord"},{"key":"1021_CR28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/1520-7560(200005\/06)16:3<192::AID-DMRR114>3.0.CO;2-G","volume":"16","author":"JP Bastard","year":"2000","unstructured":"Bastard JP, Pi\u00e9roni L, Hainque B (2000) Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance. Diabetes Metab Res Rev 16:192\u2013201","journal-title":"Diabetes Metab Res Rev"},{"key":"1021_CR29","doi-asserted-by":"crossref","first-page":"R1563","DOI":"10.1152\/ajpregu.00093.2009","volume":"297","author":"R Serrano","year":"2009","unstructured":"Serrano R, Barrenetxe J, Orbe J, Rodr\u00edguez JA, Gallardo N, Mart\u00ednez C et al (2009) Tissue-specific PAI-1 gene expression and glycosylation pattern in insulin-resistant old rats. Am J Physiol Regul Integr Comp Physiol 297:R1563\u2013R1569","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1021_CR30","first-page":"515","volume":"48","author":"A Ozolina","year":"2012","unstructured":"Ozolina A, Strike E, Jaunalksne I, Serova J, Romanova T, Zake LN et al (2012) Influence of PAI-1 gene promoter-675 (4G\/5G) polymorphism on fibrinolytic activity after cardiac surgery employing cardiopulmonary bypass. Medicina (Kaunas) 48:515\u2013520","journal-title":"Medicina (Kaunas)"},{"key":"1021_CR31","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/hc3301.092803","volume":"104","author":"K Kaikita","year":"2001","unstructured":"Kaikita K, Fogo AB, Ma L, Schoenhard JA, Brown NJ, Vaughan DE (2001) Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition. Circulation 104:839\u2013844","journal-title":"Circulation"},{"key":"1021_CR32","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1006\/jmcc.2002.2001","volume":"34","author":"K Kaikita","year":"2002","unstructured":"Kaikita K, Schoenhard JA, Painter CA, Ripley RT, Brown NJ, Fogo AB et al (2002) Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition. J Mol Cell Cardiol 34:617\u2013627","journal-title":"J Mol Cell Cardiol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-013-1021-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-013-1021-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-013-1021-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T18:07:29Z","timestamp":1647022049000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-013-1021-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["1021"],"URL":"https:\/\/doi.org\/10.1007\/s11239-013-1021-x","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,7]]}}}